Filing Flows › Comparisons › LFCR vs VSTM
Lifecore Biomedical vs Verastem: LFCR and VSTM compared
Lifecore Biomedical is the larger company: $25.3M of revenue in its latest quarter (Q1 FY27) against $24.0M for Verastem (Q3 2026). Verastem is growing faster (+114% against -19% a year earlier). Lifecore Biomedical is more profitable, with an operating margin of -3.5% against -313.3%.
Where the money goes: LFCR and VSTM
Lifecore Biomedical (LFCR) · Q1 FY27
Lifecore Biomedical, Q1 FY27: revenue $25.3M (-19% year over year), operating margin -3.5%, net loss $40.1M, operating cash flow $6.9M. The chart follows the revenue to costs, profit and cash.
Verastem (VSTM) · Q3 2026
Verastem, Q3 2026: revenue $24.0M (+114% year over year), operating margin -313.3%, net loss $74.7M, operating cash flow −$33.6M. The chart follows the revenue to costs, profit and cash.
| Lifecore Biomedical (LFCR) | Verastem (VSTM) | |
|---|---|---|
| Latest quarter | Q1 FY27 | Q3 2026 |
| Revenue | $25.3M | $24.0M |
| Revenue growth, Y/Y | -19% | +114% |
| Operating margin | -3.5% | -313.3% |
| Net earnings | −$40.1M | −$74.7M |
| Net margin | -158.3% | -311.2% |
| Operating cash flow | $6.9M | −$33.6M |
| Free cash flow | $6.0M | — |
| Market value | — | $839M |
| Analysts’ mean target | — | $17.22 |
Where the revenue comes from
Lifecore Biomedical
- CDMO: $17.8M (70%)
- HA manufacturing: $7.5M (30%)
Questions
Which is bigger, Lifecore Biomedical or Verastem?
Lifecore Biomedical is the larger company: $25.3M of revenue in its latest quarter (Q1 FY27) against $24.0M for Verastem (Q3 2026).
Is Lifecore Biomedical or Verastem growing faster?
Verastem is growing faster (+114% against -19% a year earlier).
Which is more profitable, Lifecore Biomedical or Verastem?
Lifecore Biomedical is more profitable, with an operating margin of -3.5% against -313.3%.
More: Lifecore Biomedical earnings · how Lifecore Biomedical makes money · Verastem earnings · how Verastem makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.